113 related articles for article (PubMed ID: 31658331)
1. Immunoexpression of E-cadherin, P-cadherin and fibronectin in gastric carcinomas.
Dobriţoiu M; Stepan AE; Mărgăritescu C; Simionescu CE; Vere CC; Schenker M; Crişan AE
Rom J Morphol Embryol; 2019; 60(2):573-579. PubMed ID: 31658331
[TBL] [Abstract][Full Text] [Related]
2. E-cadherin, fibronectin and Slug immunoexpression in non-melanoma skin cancers.
Ciuciulete AR; Stepan AE; Badiu AM; Andreiana BC; Florescu MM; Simionescu CE; Vîlcea AM
Rom J Morphol Embryol; 2021; 62(3):705-712. PubMed ID: 35263398
[TBL] [Abstract][Full Text] [Related]
3. E-cadherin in gastric carcinomas: Relations with histological parameters and its prognostic value.
Schizas D; Moris D; Michalinos A; Kanavidis P; Oikonomou D; Papalampros A; Machairas A; Liakakos T
J BUON; 2017; 22(2):383-389. PubMed ID: 28534359
[TBL] [Abstract][Full Text] [Related]
4. Morphological and immunohistochemical identification of epithelial-to-mesenchymal transition in clinical prostate cancer.
Kolijn K; Verhoef EI; van Leenders GJ
Oncotarget; 2015 Sep; 6(27):24488-98. PubMed ID: 26041890
[TBL] [Abstract][Full Text] [Related]
5. The cadherin switch assessment in the epithelial-mesenchymal transition of urothelial bladder carcinomas.
Drocaş AI; Tomescu PI; Mitroi G; Drăgoescu PO; Mărgăritescu C; Stepan AE; Şurlin V; CrăiŢoiu Ş; Drocaş I; Ungureanu AM; Găman AE; Turculeanu A; Simionescu CE
Rom J Morphol Embryol; 2016; 57(3):1037-1044. PubMed ID: 28002521
[TBL] [Abstract][Full Text] [Related]
6. E-cadherin regulators are differentially expressed in the epithelium and stroma of keratocystic odontogenic tumors.
Porto LP; dos Santos JN; Ramalho LM; Figueiredo AL; Carneiro Júnior B; Gurgel CA; Paiva KB; Xavier FC
J Oral Pathol Med; 2016 Apr; 45(4):302-11. PubMed ID: 26525778
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of gastric cancer cell invasion by Twist is accompanied by N-cadherin and fibronectin expression.
Yang Z; Zhang X; Gang H; Li X; Li Z; Wang T; Han J; Luo T; Wen F; Wu X
Biochem Biophys Res Commun; 2007 Jul; 358(3):925-30. PubMed ID: 17512904
[TBL] [Abstract][Full Text] [Related]
8. Gastric and intestinal phenotypic cell marker expressions in gastric differentiated-type carcinomas: association with E-cadherin expression and chromosomal changes.
Morohara K; Tajima Y; Nakao K; Nishino N; Aoki S; Kato M; Sakamoto M; Yamazaki K; Kaetsu T; Suzuki S; Tsunoda A; Tachikawa T; Kusano M
J Cancer Res Clin Oncol; 2006 Jun; 132(6):363-75. PubMed ID: 16447040
[TBL] [Abstract][Full Text] [Related]
9. Association of E-cadherin and beta-catenin immunoexpression with clinicopathologic features in primary ovarian carcinomas.
Faleiro-Rodrigues C; Macedo-Pinto I; Pereira D; Ferreira VM; Lopes CS
Hum Pathol; 2004 Jun; 35(6):663-9. PubMed ID: 15188131
[TBL] [Abstract][Full Text] [Related]
10. Decreased Expression of Caveolin-1 and E-Cadherin Correlates with the Clinicopathologic Features of Gastric Cancer and the EMT Process.
Zhang K; Yang G; Wu W; Zhang J; Xia X; Jiang T; Cao J; Huang K; Qiu Z; Huang C
Recent Pat Anticancer Drug Discov; 2016; 11(2):236-44. PubMed ID: 26817615
[TBL] [Abstract][Full Text] [Related]
11. Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer.
Ryu HS; Park DJ; Kim HH; Kim WH; Lee HS
Hum Pathol; 2012 Apr; 43(4):520-8. PubMed ID: 22018628
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of altering epithelial-mesenchymal transition in metastatic lymph nodes of gastric cancer.
Okubo K; Uenosono Y; Arigami T; Yanagita S; Matsushita D; Kijima T; Amatatsu M; Uchikado Y; Kijima Y; Maemura K; Natsugoe S
Gastric Cancer; 2017 Sep; 20(5):802-810. PubMed ID: 28247164
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of N-cadherin expression in gastric cancer.
Kamikihara T; Ishigami S; Arigami T; Matsumoto M; Okumura H; Uchikado Y; Kita Y; Kurahara H; Kijima Y; Ueno S; Natsugoe S
Pathol Int; 2012 Mar; 62(3):161-6. PubMed ID: 22360503
[TBL] [Abstract][Full Text] [Related]
14. E-cadherin÷CD44 immunophenotype in the epithelial-mesenchymal transition of bladder urothelial carcinomas.
Stepan AE; Pirici D; Bălăşoiu M; Novac MB; Drocaş AI; Ciurea RN; Stepan D; Gheonea DI; Simionescu CE
Rom J Morphol Embryol; 2015; 56(1):85-91. PubMed ID: 25826491
[TBL] [Abstract][Full Text] [Related]
15. [Expression of LMP2A, E-Cadherin and fibronectin in nasopharyngeal carcinoma and its clinical significance].
Zhao L; Rao J; Luo B; Chen X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jan; 29(2):132-6. PubMed ID: 25989660
[TBL] [Abstract][Full Text] [Related]
16. GM130 regulates epithelial-to-mesenchymal transition and invasion of gastric cancer cells via snail.
Zhao J; Yang C; Guo S; Wu Y
Int J Clin Exp Pathol; 2015; 8(9):10784-91. PubMed ID: 26617790
[TBL] [Abstract][Full Text] [Related]
17. The Lauren classification highlights the role of epithelial-to-mesenchymal transition in gastric carcinogenesis: an immunohistochemistry study of the STAT3 and adhesion molecules expression.
Susman S; Barnoud R; Bibeau F; Borrini F; Pocard M; Tomuleasa C; Sabourin JC
J Gastrointestin Liver Dis; 2015 Mar; 24(1):77-83. PubMed ID: 25822437
[TBL] [Abstract][Full Text] [Related]
18. Immunoexpression of E-cadherin, CD44 and Claudin 7 in gastric adenocarcinomas.
Creţu OI; Simionescu CE; Florescu MM; Stepan MD; Sapalidis K; Stepan AE
Rom J Morphol Embryol; 2022; 63(3):529-537. PubMed ID: 36588491
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical Study EMT-Related Proteins in HPV-, and EBV-Negative Patients with Sinonasal Tumours.
Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Danilewicz M
Pathol Oncol Res; 2016 Oct; 22(4):781-8. PubMed ID: 27138192
[TBL] [Abstract][Full Text] [Related]
20. Epithelial-mesenchymal Transition (EMT) Markers in Human Pituitary Adenomas Indicate a Clinical Course.
Jia W; Zhu J; Martin TA; Jiang A; Sanders AJ; Jiang WG
Anticancer Res; 2015 May; 35(5):2635-43. PubMed ID: 25964539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
